Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 17/20 | 0.37 |
| ▸ | PPARA | Q07869 | 14/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | PPARD | Q03181 | 2/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31094990 | 0.93 | PPARG (0.32) | PPARG | |
| SCHEMBL31095002 | 0.90 | PPARG (0.42) | PPARGPPARAKDM4EPPARDFFAR1 | |
| SCHEMBL31094992 | 0.89 | PPARG (0.40) | PPARGPPARAKDM4EPPARDFFAR1 | |
| SCHEMBL31095004 | 0.84 | KDM4E (0.52) | PPARGPPARAKDM4EPPARDHRH3 | |
| SCHEMBL31095012 | 0.81 | PPARG (0.34) | PPARGPPARAKDM4EPPARDFFAR1 | |
| SCHEMBL31095024 | 0.79 | PPARG (0.46) | PPARGPPARAKDM4EPPARDFFAR1 | |
| SCHEMBL30193376 | 0.77 | KDM4E (0.39) | PPARGPPARAKDM4EPPARDFFAR1 | |
| SCHEMBL31095020 | 0.77 | PPARG (0.45) | PPARGPPARAKDM4EPPARDHRH3 | |
| SCHEMBL30193484 | 0.76 | KDM4E (0.40) | PPARGPPARAKDM4EPPARDFFAR1 | |
| SCHEMBL821405 | 0.70 | PPARG (0.59) | PPARGPPARAKDM4EPPARDHRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240270731-A1 | DEUTERATED COMPOUNDS | ALEBUND PHARMACEUTICALS (HONG KONG) LIMITED (CN) | 2024-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240270731-A1 | DEUTERATED COMPOUNDS | CYP2D6, CYP11B2, DHCR7 | PPARG 451/4885PPARA 601/4885KDM4E 4082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.